RECURRING REVENUE

Creso delivers second consecutive quarter of record revenue growth

Finfeed Archived Jul 01, 2021

Creso Pharma (ASX: CPH) has achieved strong sales growth for the June quarter generating a total of A$1,715,933 - a 24% increase on the previous quarter (Q1 CY2021: A$1,385,000).

Vonex seals the deal on earnings accretive Nextel acquisition

Finfeed Archived Feb 03, 2021

Vonex (ASX: VN8) has completed its acquisition of Nextel, a business that generated $2 million in revenues in fiscal 2020.

Creso Pharma delivers second shipment of cannaQIX® adding $320K to growing revenue base

Finfeed Archived Jan 12, 2021

Creso Pharma has delivered a second shipment of cannaQIX® products to Lupin International subsidiary, Pharma Dynamics

Vonex delivering outstanding growth with more to come in fiscal 2021

Finfeed Archived Jul 30, 2020

Vonex (ASX: VN8) has released its June quarter update, featuring the strongest operational and financial quarter it has delivered

Simble grows SimbleSense and makes sustainable cost cuts

Finfeed Archived Jul 13, 2020

Simble Solutions (ASX:SIS) opened 10% higher on Monday after the company released an impressive June quarter report.

Vonex shares respond positively to stellar June half performance

Finfeed Archived Jul 08, 2020

Vonex Ltd (ASX:VN8) shares traded 9% higher in response to a strong June half which featured outstanding growth in recurring revenues

Vonex Share Price Set to Double, Says Analyst

Next Investors Archived Apr 30, 2020

PAC Partners analyst Mark Yarwood ran the ruler across Vonex (ASX: VN8) recently, attributing a 12-month target price of 20 cents per share to the stock, implying upside of 100%.

Recurring Revenue